WIZBIOTECH SARS-CoV-2 Rapid Antigen Test (Colloidal Gold) collects samples from the front of the nose instead of the nasopharynx, resulting in simplified and rapid detection procedures. This testing method can help reduce the overall discomfort of patients, especially sensitive individuals, such as children, the elderly, or disabled people.
Besides being less invasive, the test also provides patients with the option of collecting nasal samples by themselves under the supervision of healthcare professionals. By reducing physical contact, this test method helps to reduce the risk of medical staff exposure to the virus. Whether the test can be used without the supervision of medical professionals will depend on local regulatory requirements.